Scott Curry

2.8k total citations · 1 hit paper
32 papers, 2.1k citations indexed

About

Scott Curry is a scholar working on Infectious Diseases, Epidemiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Scott Curry has authored 32 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 18 papers in Epidemiology and 7 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Scott Curry's work include Clostridium difficile and Clostridium perfringens research (22 papers), Microscopic Colitis (15 papers) and Viral gastroenteritis research and epidemiology (7 papers). Scott Curry is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (22 papers), Microscopic Colitis (15 papers) and Viral gastroenteritis research and epidemiology (7 papers). Scott Curry collaborates with scholars based in United States, Czechia and Netherlands. Scott Curry's co-authors include Ashwin N. Ananthakrishnan, David G. Binion, Lawrence J. Brandt, Brian S. Zuckerbraun, Lynne V. McFarland, Christina M. Surawicz, Mark Mellow, Peter H. Gilligan, Lee H. Harrison and Jane W. Marsh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied and Environmental Microbiology and Clinical Infectious Diseases.

In The Last Decade

Scott Curry

26 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

2013 1.2k citations Christina M. Surawicz, Lawrence J. Brandt et al. The American Journal of Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Curry United States	13	2.0k	1.4k	445	362	317	32	2.1k
S. B. Debast Netherlands	15	1.9k 1.0×	1.4k 1.0×	396 0.9×	323 0.9×	231 0.7×	24	2.1k
Mark Mellow United States	11	1.8k 0.9×	1.4k 1.0×	603 1.4×	205 0.6×	608 1.9×	16	2.3k
Torbjörn Norén Sweden	19	1.2k 0.6×	787 0.6×	245 0.6×	224 0.6×	247 0.8×	39	1.4k
M.P.M. Hensgens Netherlands	15	1.2k 0.6×	844 0.6×	237 0.5×	265 0.7×	167 0.5×	19	1.3k
Anne J Gonzales-Luna United States	16	969 0.5×	631 0.5×	310 0.7×	142 0.4×	306 1.0×	64	1.2k
Elena Reigadas Spain	19	1.1k 0.6×	771 0.6×	176 0.4×	216 0.6×	224 0.7×	63	1.3k
Monique J. T. Crobach Netherlands	13	1.1k 0.6×	870 0.6×	215 0.5×	253 0.7×	151 0.5×	21	1.3k
Dale N. Gerding United States	15	1.4k 0.7×	936 0.7×	303 0.7×	294 0.8×	155 0.5×	17	1.7k
Fred A. Zar United States	10	966 0.5×	847 0.6×	281 0.6×	159 0.4×	61 0.2×	19	1.2k
Tiffany Hink United States	14	719 0.4×	473 0.3×	93 0.2×	137 0.4×	325 1.0×	31	1.0k

Countries citing papers authored by Scott Curry

Since Specialization

Citations

This map shows the geographic impact of Scott Curry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Curry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Curry more than expected).

Fields of papers citing papers by Scott Curry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Curry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Curry. The network helps show where Scott Curry may publish in the future.

Co-authorship network of co-authors of Scott Curry

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Curry. A scholar is included among the top collaborators of Scott Curry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Curry. Scott Curry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Curry, Scott, et al.. (2026). P-2111. Heart Transplant Candidates and Strongyloides stercoralis: Screening Outcomes and Testing Rates in Solid Organ Transplants. Open Forum Infectious Diseases. 13(Supplement_1).

Curry, Scott, Bradford P. Taylor, Jacquelyn Turcinovic, et al.. (2025). Characterisation of a persistent SARS-CoV-2 infection lasting more than 750 days in a person living with HIV: a genomic analysis. The Lancet Microbe. 6(9). 101122–101122.

Curry, Scott, et al.. (2025). Verruconis gallopava : an isavuconazonium foe. PubMed. 1(5).

Meissner, Eric G., et al.. (2024). Candida auris cluster in a center with no previous infections associated with a single organ donor. SHILAP Revista de lepidopterología. 4(S1). s128–s128.

Curry, Scott, Michelle T. Hecker, Justin J. O’Hagan, et al.. (2024). Incubation period of Clostridioides difficile infection in hospitalized patients and long-term care facility residents: a prospective cohort study. SHILAP Revista de lepidopterología. 4(1). 1 indexed citations

Curry, Scott, Michelle T. Hecker, Justin J. O’Hagan, et al.. (2023). Natural History of Clostridioides difficile Colonization and Infection Following New Acquisition of Carriage in Healthcare Settings: A Prospective Cohort Study. Clinical Infectious Diseases. 77(1). 77–83. 10 indexed citations

Taylor, Bradford P., Jacquelyn Turcinovic, Xueting Qiu, et al.. (2023). Successful treatment of SARS-CoV-2 in an immunocompromised patient with persistent infection for 245 days: A case report. Heliyon. 10(1). e23699–e23699. 5 indexed citations

Hughes, Heather, et al.. (2020). Potential for the current National Healthcare Safety Network (NHSN) >3 days after admission definition of laboratory-identified, healthcare-facility–onset, Clostridioides difficile infection (HO-CDI) to overestimate rates. Infection Control and Hospital Epidemiology. 41(4). 467–468.

Curry, Scott & Cassandra D. Salgado. (2020). When Hospitals Harm: Multimodal Entry of SARS-CoV-2 into Inpatient Healthcare. Clinical Infectious Diseases. 72(4). 694–696. 2 indexed citations

10.

Curry, Scott. (2017). Clostridium difficile. Clinics in Laboratory Medicine. 37(2). 341–369. 19 indexed citations

11.

Curry, Scott, et al.. (2014). AsymptomaticClostridium difficilecolonization as a reservoir forClostridium difficileinfection. Expert Review of Anti-infective Therapy. 12(8). 967–980. 27 indexed citations

12.

Muto, Carlene A., et al.. (2014). 1646Evidence of hospital-associated Clostridium difficile transmission between patients with asymptomatic carriage and patients with Clostridium difficile infection. Open Forum Infectious Diseases. 1(suppl_1). S440–S440. 1 indexed citations

13.

Curry, Scott, Carlene A. Muto, Jessica L. Schlackman, et al.. (2013). Use of Multilocus Variable Number of Tandem Repeats Analysis Genotyping to Determine the Role of Asymptomatic Carriers in Clostridium difficile Transmission. Clinical Infectious Diseases. 57(8). 1094–1102. 169 indexed citations

14.

Surawicz, Christina M., Lawrence J. Brandt, David G. Binion, et al.. (2013). Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections. The American Journal of Gastroenterology. 108(4). 478–498. 1223 indexed citations breakdown →

15.

Bartsch, Sarah M., et al.. (2012). The potential economic value of screening hospital admissions for Clostridium difficile. European Journal of Clinical Microbiology & Infectious Diseases. 31(11). 3163–3171. 30 indexed citations

16.

Marsh, Jane W., et al.. (2012). Association of Relapse of Clostridium difficile Disease with BI/NAP1/027. Journal of Clinical Microbiology. 50(12). 4078–4082. 112 indexed citations

17.

Curry, Scott, Jessica L. Schlackman, Jane W. Marsh, et al.. (2011). Perirectal Swab Surveillance for Clostridium difficile by Use of Selective Broth Preamplification and Real-Time PCR Detection of tcdB. Journal of Clinical Microbiology. 49(11). 3788–3793. 31 indexed citations

18.

Curry, Scott. (2010). Clostridium difficile. Clinics in Laboratory Medicine. 30(1). 329–342. 23 indexed citations

19.

Curry, Scott, Jane W. Marsh, Kathleen A. Shutt, et al.. (2009). High Frequency of Rifampin Resistance Identified in an EpidemicClostridium difficileClone from a Large Teaching Hospital. Clinical Infectious Diseases. 48(4). 425–429. 134 indexed citations

20.

Curry, Scott, Jane W. Marsh, Carlene A. Muto, et al.. (2006). tcdC Genotypes Associated with Severe TcdC Truncation in an Epidemic Clone and Other Strains of Clostridium difficile. Journal of Clinical Microbiology. 45(1). 215–221. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact